Table 2.
Baseline | Immediate post | Two month followup | |
---|---|---|---|
Control Group (N = 56) | |||
FACIT-Sp Meaning/Peace | 22.28 (6.10) | 22.58 (6.23) | 22.83 (5.88) |
FACIT-Sp Faith | 11.13 (4.63) | 10.67 (4.96) | 10.71 (4.81) |
BDI | 15.36 (8.57) | 11.50 (8.99) | 11.14 (8.75) |
BES | 19.25 (9.39) | 17.43 (9.85) | 16.32 (9.39) |
BAI | 29.96 (7.49) | 30.05 (7.94) | |
FFMQ Observe | 25.79 (4.83) | 25.97 (5.30) | 25.37 (5.76) |
FFMQ Describe | 27. 31 (6.70) | 27.41 (6.98) | 27.51 (7.40) |
FFMQ Awareness | 27.62 (5.52) | 27.39 (5.42) | 27.42 (5.98) |
FFMQ Non-judging | 27.66 (5.57) | 29.15 (6.18) | 29.33 (6.46) |
FFMQ Non-reactive | 23.15 (4.58) | 23.53 (4.92) | 23.22 (5.25) |
Treatment Group (N = 61) | |||
FACIT-Sp Meaning/Peace | 21.73 (5.21) | 23.80 (6.11) | 24.21 (6.05) |
FACIT-Sp Faith | 10.37 (4.87) | 11.81 (4.23) | 11.99 (4.18) |
BDI | 14.67 (9.36) | 8.42 (8.43) | 8.25 (9.60) |
BES | 18.97 (10.12) | 12.49 (8.70) | 11.83 (9.37) |
BAI | 29.97 (6.91) | 28.95 (7.44) | |
FFMQ Observe | 27.28 (5.50) | 28.28 (4.71) | 28.52 (4.95) |
FFMQ Describe | 27.23 (6.26) | 27.62 (6.49) | 27.72 (7.18) |
FFMQ Awareness | 26.69 (5.12) | 27.63 (5.64) | 28.62 (5.91) |
FFMQ Non-judging | 26.88 (5.72) | 27.48 (6.53) | 28.89 (6.53) |
FFMQ Non-reactive | 21.88 (4.04) | 21.76 (3.81) | 22.61 (3.54) |